Literature DB >> 24333729

The ING tumor suppressor genes: status in human tumors.

Claire Guérillon1, Nicolas Bigot1, Rémy Pedeux2.   

Abstract

ING genes (ING1-5) were identified has tumor suppressor genes. ING proteins are characterized as Type II TSGs since they are involved in the control of cell proliferation, apoptosis and senescence. They may also function as Type I TSGs since they are also involved in DNA replication and repair. Most studies have reported that they are frequently lost in human tumors and epigenetic mechanisms or misregulation of their transcription may be involved. Recently, studies have described that this loss may be caused by microRNA inhibition. Here, we summarize the current knowledge on ING functions, their involvement in tumor suppression and, in order to give a full assessment of the current knowledge, we review all the studies that have examined ING status in human cancers.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  ING1; ING4; MicroRNA; Tumor suppressor gene; p53

Mesh:

Substances:

Year:  2013        PMID: 24333729     DOI: 10.1016/j.canlet.2013.11.016

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  23 in total

1.  ING3 is required for ATM signaling and DNA repair in response to DNA double strand breaks.

Authors:  Audrey Mouche; Jérôme Archambeau; Charles Ricordel; Laura Chaillot; Nicolas Bigot; Thierry Guillaudeux; Muriel Grenon; Rémy Pedeux
Journal:  Cell Death Differ       Date:  2019-02-25       Impact factor: 15.828

2.  Identification of the inhibitor of growth protein 4 (ING4) as a potential target in prostate cancer therapy.

Authors:  Aymen Shatnawi; Sridhar A Malkaram; Tamer Fandy; Efrosini Tsouko
Journal:  Mol Cell Biochem       Date:  2019-11-27       Impact factor: 3.396

3.  A novel tumor suppressor gene in basal cell carcinoma: inhibition of growth factor-2.

Authors:  Metin Temel; Arif Turkmen; Recep Dokuyucu; Cengiz Cevik; Serdar Oztuzcu; Beyhan Cengiz; Mehmet Mutaf
Journal:  Tumour Biol       Date:  2015-01-23

4.  Systematic Analysis of SIN3 Histone Modifying Complex Components During Development.

Authors:  Valerie L Barnes; Kelly A Laity; Maksymilian Pilecki; Lori A Pile
Journal:  Sci Rep       Date:  2018-11-19       Impact factor: 4.379

Review 5.  ING Proteins: Tumour Suppressors or Oncoproteins.

Authors:  Karine Jacquet; Olivier Binda
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

6.  MiR-371-5p facilitates pancreatic cancer cell proliferation and decreases patient survival.

Authors:  De He; Huilai Miao; Yumin Xu; Longhui Xiong; Yi Wang; Hongxia Xiang; Heng Zhang; Zhiyong Zhang
Journal:  PLoS One       Date:  2014-11-20       Impact factor: 3.240

7.  Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer.

Authors:  Martina Kluth; Ramin Ahrary; Claudia Hube-Magg; Malik Ahmed; Heinke Volta; Catina Schwemin; Stefan Steurer; Corinna Wittmer; Waldemar Wilczak; Eike Burandt; Till Krech; Meike Adam; Uwe Michl; Hans Heinzer; Georg Salomon; Markus Graefen; Christina Koop; Sarah Minner; Ronald Simon; Guido Sauter; Thorsten Schlomm
Journal:  Oncotarget       Date:  2015-09-29

8.  Defining the minimal peptide sequence of the ING1b tumour suppressor capable of efficiently inducing apoptosis.

Authors:  A Boyko; K Riabowol
Journal:  Cell Death Discov       Date:  2015-10-26

9.  Stromal ING1 expression induces a secretory phenotype and correlates with breast cancer patient survival.

Authors:  Satbir Thakur; Arash Nabbi; Alexander Klimowicz; Karl Riabowol
Journal:  Mol Cancer       Date:  2015-08-27       Impact factor: 27.401

10.  Oncogenic Ras suppresses ING4-TDG-Fas axis to promote apoptosis resistance.

Authors:  Jie Sun; Qi Shen; Haiqi Lu; Zhinong Jiang; Wenxia Xu; Lifeng Feng; Ling Li; Xian Wang; Xiujun Cai; Hongchuan Jin
Journal:  Oncotarget       Date:  2015-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.